Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

TEPEZZA 500 MG

TEPROTUMUMAB : 500 MG · DIN 02557061 · AMGEN CANADA INC

Health Canada status: MARKETED

What is TEPEZZA?

TEPEZZA 500 MG contains TEPROTUMUMAB : 500 MG. It is listed in the Health Canada Drug Product Database under DIN 02557061, held by AMGEN CANADA INC, supplied as POWDER FOR SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 23-Jan-2026. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN02557061
Brand nameTEPEZZA
Generic / active ingredientTEPROTUMUMAB : 500 MG
ManufacturerAMGEN CANADA INC
Strength500 MG
Dosage formPOWDER FOR SOLUTION
Route of administrationINTRAVENOUS
SchedulePrescription
ATC codeL04AG13 TEPROTUMUMAB
BiosimilarNo
Health Canada statusMARKETED
Status date23-Jan-2026

Who else supplies TEPROTUMUMAB worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. TEPROTUMUMAB appears in 2 registered pack listings across 2 markets, published on 1 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for TEPEZZA

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for TEPEZZA

Health Canada Drug Product Database (DPD), DIN 02557061. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.